HSDT
Helius Medical Technologies, Inc. News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 1,
"returned": 1,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "465c38f4-0c01-4152-a76c-e566a6f47b0f",
"title": "Helius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024",
"description": "NEWTOWN, Pa., May 10, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused...",
"keywords": "Nasdaq:HSDT, Helius Medical Technologies, Inc.",
"snippet": "NEWTOWN, Pa., May 10, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused...",
"url": "https://www.globenewswire.com/news-release/2024/05/10/2879634/0/en/Helius-Medical-Technologies-Inc-to-Release-First-Quarter-2024-Financial-Results-on-May-13-2024.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/f66facdd-4e51-49b4-b66a-d806d02134d5",
"language": "en",
"published_at": "2024-05-10T13:00:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "HSDT",
"name": "Helius Medical Technologies, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 181.47214,
"sentiment_score": 0.2488,
"highlights": [
{
"highlight": "., May 10, 2024 (GLOBE NEWSWIRE) -- <em>Helius</em> <em>Medical</em> <em>Technologies</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>NASDAQ</em>: <em>HSDT</em>) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that the Company will release its first quarter 2024 financial results on Monday, May 13, 2024, after the market closes.\n\n\n\nDane C.",
"sentiment": 0.5994,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Helius</em> <em>Medical</em> <em>Technologies</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Helius</em> <em>Medical</em> <em>Technologies</em> is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people dealing with neurologic diseases.",
"sentiment": 0.8934,
"highlighted_in": "main_text"
},
{
"highlight": "For more information about the PoNS® or <em>Helius</em> <em>Medical</em> <em>Technologies</em>, visit www.heliusmedical.com.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Helius</em> <em>Medical</em> <em>Technologies</em>, <em>Inc</em>. to Release First Quarter 2024 Financial Results on May 13, 2024",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "HSDT",
"total_documents": 1,
"sentiment_avg": 0.24879999458789825
}
]
}
Other details
Exchange
- NASDAQ Stock Exchange
- equity
- Healthcare
- us